Why is Natco Pharma falling/rising?

As of 02-Jul, Natco Pharma Ltd. is experiencing a decline in its stock price, currently at 925.00, reflecting a decrease of 11.95 points or 1.28%. The stock has underperformed its sector by 1.36% today and has fallen after three consecutive days of gains, touching an intraday low of Rs 916.6. In terms of performance over the past week, the stock has increased by 5.24%, although it has a year-to-date decline of 33.31%. Despite the recent drop, the stock's operating profit has grown at an annual rate of 32.35%, and it boasts a high return on equity (ROE) of 15.57%, indicating strong management efficiency. The stock is trading at a discount compared to its peers, which could suggest an attractive valuation despite its recent price movement.
In the broader market context, the Sensex has increased by 0.79% over the past week, while Natco Pharma's performance has outpaced this benchmark during the same period. However, the stock's year-to-date performance significantly lags behind the Sensex's 6.75% gain. The rising investor participation, indicated by a 52.89% increase in delivery volume, suggests that there is still interest in the stock, which may provide some support despite the recent price decline. The high institutional holdings at 23.15% further reflect confidence from knowledgeable investors, which could help stabilize the stock in the long run.